A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples